endocrine · Mechanism Report
Does low selenium status contribute to thyroid autoimmunity?
Low selenium status is associated with thyroid autoantibody positivity, but its causal role in autoimmune thyroid disease remains unproven.
This is what AI claimed
Selenium deficiency or low selenium status contributes to autoimmune thyroid disease or thyroid autoantibody positivity.
Executive summary
Low selenium status has been associated with thyroid autoantibody positivity and the emergence of thyroid antibodies. Selenium may influence antibody levels, but changes in these markers do not establish an effect on clinically defined autoimmune thyroid disease.
Verified conclusion
Low selenium status has a moderately supported association with thyroid autoantibody positivity, whereas a causal role in clinically defined autoimmune thyroid disease remains plausible but unproven.
Clinical and observational evidence
- In a prospective study of 367 pregnant women, plasma selenium <70 μg/L was associated with anti–thyroid peroxidase antibody (TPOAb) positivity: 13.3% versus 4.6% among women with optimal selenium status, adjusted odds ratio 4.2. The confidence interval was wide, and pregnancy-specific physiology limits generalization.
- A population cohort found greater TPOAb seroconversion in a low-selenium region even after accounting for urinary iodine (risk ratio 3.39). This temporal evidence strengthens the association with emerging thyroid autoimmunity, but residual confounding remains possible.
Supplementation and mechanistic interpretation
- Selenium plausibly modulates thyroid autoimmunity, as supplementation meta-analyses report lower TPOAb concentrations. A 2024 review of 29 cohorts found a reduction, but between-study heterogeneity was very high (I²=90%) and overall evidence quality was low.
- A separate 2023 meta-analysis also reported lower TPOAb, and reductions in antibody markers at six months, but estimates were similarly heterogeneous. Thyroglobulin antibodies did not significantly decline overall in the 2024 analysis.
- These findings support an effect on antibody biology rather than demonstrating prevention, reversal, or clinically meaningful alteration of autoimmune thyroid disease.
Clinical implications
- Available evidence centers on antibody positivity and seroconversion, not incident clinically defined autoimmune thyroid disease, progression to hypothyroidism, or patient-important outcomes.
- Routine selenium testing or supplementation solely to treat or prevent autoimmune thyroid disease is not established; ATA guidance recommends against selenium supplementation in TPOAb-positive pregnancy.
Bottom line
- Low selenium status likely contributes to thyroid autoantibody positivity, but its causal contribution to autoimmune thyroid disease itself remains uncertain and should not be inferred from antibody changes alone.
References
- Insights from a prospective ideal breast milk cohort study — pmc.ncbi.nlm.nih.gov
- Increased Incidence of Hashimoto Thyroiditis in Selenium ... — academic.oup.com
- Selenium Supplementation in Patients with Hashimoto ... - PMC — pmc.ncbi.nlm.nih.gov
- The correlation between selenium levels and autoimmune ... — pubmed.ncbi.nlm.nih.gov
See a full patient report verified like this
Book a walkthrough